pharma · Metastatic Breast Cancer · Advanced Ovarian Cancer · ALLR
Allarity Therapeutics
Allarity Therapeutics is a pharma organization headquartered in Tarpon Springs, USA. It trades on NYSE under ticker ALLR. Primary therapeutic focus areas include Metastatic Breast Cancer, Advanced Ovarian Cancer, Advance
Tarpon Springs, USA HQ
2012 Founded
11 Employees
Public company Type
ALLR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tarpon Springs, USA
- Founded
- 2012
- Employees
- 11
- Programs
- 7
- Drugs
- 4
- Patents
- 1
2X-121 and dovitinib
Phase 1 · small molecule · Advanced Solid Tumors
2X-121 and dovitinib for Advanced Solid Tumors is a Phase 1 program (small_molecule) at Allarity Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code AL-2003
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Allarity Therapeutics
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Advanced Solid Tumors
- Status
- on_hold
- Trials
- 1